• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DENTEK ORAL CARE, INC. DENTEK TEMPARIN MAX REPAIR KIT; ZINC OXIDE EUGENOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DENTEK ORAL CARE, INC. DENTEK TEMPARIN MAX REPAIR KIT; ZINC OXIDE EUGENOL Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problems Dyspnea (1816); Extreme Exhaustion (1843); Headache (1880); Hypersensitivity/Allergic reaction (1907); Dizziness (2194); Shaking/Tremors (2515); Swelling/ Edema (4577)
Event Date 06/17/2023
Event Type  Injury  
Event Description
I used dentek to apply to a cracked tooth, before going to bed.The next morning i was dizzy, short of breath, shaking, headache, and i felt exhausted, my tongue, throat and mouth was swollen and raw.After realizing that the dentek was the only thing i had done different, i removed it from my tooth, however the effects l experienced for 5 days afterward.And because of the symptoms i was unable to go to work.Slowly things have returned to normal but i will never use this product again.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENTEK TEMPARIN MAX REPAIR KIT
Type of Device
ZINC OXIDE EUGENOL
Manufacturer (Section D)
DENTEK ORAL CARE, INC.
MDR Report Key17217900
MDR Text Key318115928
Report NumberMW5118875
Device Sequence Number1
Product Code EMB
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
LOSARTAN
Patient Outcome(s) Other;
Patient Age55 YR
Patient SexFemale
Patient Weight99 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-